Tokyo Tape
Sign in
← J Frontier

Quarterly report · Q3

2934.TEDINET S100UXBC
Period2023-06-01 → 2024-02-29
Filed2024-12-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed

Amends S100T9GJ. Amended by S100UXGM (2024-12-11).

Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥12.4bn2023-06-01 → 2024-02-29Cons.Net sales
Revenue¥16.8bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥12.7bn2022-06-01 → 2023-02-28Cons.Net sales
Operating income−¥542m2023-06-01 → 2024-02-29Cons.Operating income
Operating income−¥718m2022-06-01 → 2023-02-28Cons.Operating income
Ordinary income−¥552m2023-06-01 → 2024-02-29Cons.Ordinary income
Ordinary income−¥1.8bn2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥737m2022-06-01 → 2023-02-28Cons.Ordinary income
Profit before tax−¥554m2023-06-01 → 2024-02-29Cons.Income before income taxes
Profit before tax−¥738m2022-06-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)−¥638m2023-06-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.9bn2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥615m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income−¥632m2023-06-01 → 2024-02-29Cons.Profit loss
Net income−¥577m2022-06-01 → 2023-02-28Cons.Profit loss
Total assets¥8.7bnat 2024-02-29Cons.Assets
Total assets¥7.2bnat 2023-05-31Cons.Assets
Total assets¥7.8bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥5.9bnat 2024-02-29Cons.Liabilities
Total liabilities¥4.5bnat 2023-05-31Cons.Liabilities
Net assets / equity¥2.8bnat 2024-02-29Cons.Net assets
Net assets / equity¥2.7bnat 2023-05-31Cons.Net assets
Net assets / equity¥4.0bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥1.2bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥1.6bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥-131.132023-06-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-71.252023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-410.62022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-133.62022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-55.92022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio29.2%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio34.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.0%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-06-01 → 2024-02-29−¥172m
Reconciling Itemsreconcilingrevenue intersegment2023-06-01 → 2024-02-29−¥172m
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2024-02-29−¥438m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥4.2bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥4.1bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥165m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2023-06-01 → 2024-02-29¥27m
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥150,000
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥72m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥5.3bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥5.3bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥7m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥59m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥12.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥12.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-06-01 → 2024-02-29¥172m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29−¥103m
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-02-28−¥139m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-02-28−¥139m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥385m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥4.0bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥3.9bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥139m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥19m
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥224m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥458,000
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥576m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥12.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-02-28¥139m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28−¥333m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 352
ItemContextValueUnit
Accrued expensesPrior1YearInstant195511000JPY
Accrued expensesCurrentQuarterInstant157340000JPY
Income taxes payablePrior1YearInstant61092000JPY
Income taxes payableCurrentQuarterInstant77392000JPY
Accrued consumption taxesPrior1YearInstant44735000JPY
Accrued consumption taxesCurrentQuarterInstant52548000JPY
Advances receivedPrior1YearInstant92568000JPY
Advances receivedCurrentQuarterInstant119224000JPY
Provision for bonusesPrior1YearInstant4400000JPY
Provision for bonusesCurrentQuarterInstant12277000JPY
Provision for point card certificates clPrior1YearInstant28356000JPY
Provision for point card certificates clCurrentQuarterInstant36902000JPY
Other clPrior1YearInstant66447000JPY
Other clCurrentQuarterInstant250159000JPY
Current liabilitiesPrior1YearInstant3019822000JPY
Current liabilitiesCurrentQuarterInstant4118011000JPY
Bonds payablePrior1YearInstant50000000JPY
Bonds payableCurrentQuarterInstant－JPY
Long term loans payablePrior1YearInstant1322294000JPY
Long term loans payableCurrentQuarterInstant1638239000JPY
Asset retirement obligations nclPrior1YearInstant32835000JPY
Asset retirement obligations nclCurrentQuarterInstant32989000JPY
Other nclPrior1YearInstant100801000JPY
Other nclCurrentQuarterInstant87803000JPY
Noncurrent liabilitiesPrior1YearInstant1505931000JPY
Noncurrent liabilitiesCurrentQuarterInstant1759032000JPY
LiabilitiesPrior1YearInstant4525753000JPY
LiabilitiesCurrentQuarterInstant5877044000JPY
Capital stockPrior1YearInstant165462000JPY
Capital stockCurrentQuarterInstant516583000JPY
Capital surplusPrior1YearInstant3022845000JPY
Capital surplusCurrentQuarterInstant3373966000JPY
Retained earningsPrior1YearInstant-268964000JPY
Retained earningsCurrentQuarterInstant-906489000JPY
Treasury stockPrior1YearInstant-452358000JPY
Treasury stockCurrentQuarterInstant-452804000JPY
Shareholders equityPrior1YearInstant2466984000JPY
Shareholders equityCurrentQuarterInstant2531256000JPY
Subscription rights to sharesPrior1YearInstant10125000JPY
Subscription rights to sharesCurrentQuarterInstant505000JPY
Non controlling interestsPrior1YearInstant237684000JPY
Non controlling interestsCurrentQuarterInstant249928000JPY
Net assetsPrior1YearInstant2714794000JPY
Net assetsCurrentQuarterInstant2781690000JPY
Liabilities and net assetsPrior1YearInstant7240548000JPY
Liabilities and net assetsCurrentQuarterInstant8658735000JPY
Net salesPrior1YTDDuration12720969000JPY
Net salesCurrentYTDDuration12377973000JPY
Cost of salesPrior1YTDDuration7608641000JPY
Cost of salesCurrentYTDDuration6466228000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass